Cathie Wood Goes Big on Roblox Stock While Dumping Meta Platforms

TLDR

• Cathie Wood’s ARK ETFs bought 169,130 Roblox shares worth $13.7 million on January 6, 2026
• ARK sold 19,316 Meta Platforms shares valued at $12.7 million across multiple ETFs
• ARK purchased 39,296 Kodiak AI shares worth $409,000 through its robotics ETF
• ARK reduced biotech holdings by selling $1.8 million in Guardant Health and $568,000 in Ionis Pharmaceuticals
• The trades show ARK’s shift toward gaming and AI companies while reducing exposure to Meta and healthcare stocks

Cathie Wood’s ARK Invest made several portfolio changes on January 6, 2026, with major moves in Roblox and Meta Platforms. The trades revealed a continued focus on gaming and autonomous technology while scaling back positions in social media and biotech.

ARK purchased 169,130 shares of Roblox Corp across three of its ETFs. The buying spanned the ARK Innovation ETF, ARK Next Generation Internet ETF, and ARK Fintech Innovation ETF. The total purchase value reached $13.7 million.

Roblox Corporation, RBLX

The Roblox purchase builds on previous investments in the gaming platform. ARK has shown consistent interest in the company over recent trading sessions. The online gaming platform remains part of ARK’s growth strategy.

On the selling side, ARK reduced its Meta Platforms position. The firm sold 19,316 shares across the same three ETFs used for the Roblox purchase. The Meta sale totaled $12.7 million in value.

ARK Adds to AI and Robotics Holdings

The Meta sale continues a pattern of reduced exposure to the social media company. ARK has been trimming its Meta stake in multiple recent trading sessions. The selling trend suggests a shift in Wood’s outlook for the stock.

ARK also increased its position in Kodiak AI. The autonomous driving technology company saw purchases through the ARK Autonomous Technology & Robotics ETF. ARK bought 39,296 shares of Kodiak AI for approximately $409,000.

The Kodiak AI purchase follows recent accumulation in the stock. ARK has been building its position in the autonomous driving company over several days. The moves reflect Wood’s continued interest in AI and robotics sectors.

Healthcare Holdings Face Reductions

ARK reduced two biotech positions on Tuesday. The firm sold 17,613 shares of Guardant Health through its ARK Genomic Revolution ETF. The sale was worth around $1.8 million.

ARK also cut its stake in Ionis Pharmaceuticals. The firm sold 7,228 shares valued at roughly $568,000. Both sales came exclusively through the genomics-focused ETF.

Wall Street analysts maintain mixed views on these stocks. Roblox holds a Moderate Buy rating with high upside potential. Kodiak AI and Meta both carry Strong Buy consensus ratings.

The biotech names Guardant Health and Ionis also have Strong Buy ratings from analysts. However, their projected upside is lower compared to the technology stocks. The ARK trades were published in the firm’s daily trade filings for January 6, 2026.

The post Cathie Wood Goes Big on Roblox Stock While Dumping Meta Platforms appeared first on CoinCentral.